nodes	percent_of_prediction	percent_of_DWPC	metapath
Lurasidone—CYP3A4—Estropipate—osteoporosis	0.0671	0.181	CbGbCtD
Lurasidone—CYP3A4—Calcitriol—osteoporosis	0.0671	0.181	CbGbCtD
Lurasidone—CYP3A4—Ergocalciferol—osteoporosis	0.0536	0.145	CbGbCtD
Lurasidone—CYP3A4—Raloxifene—osteoporosis	0.0448	0.121	CbGbCtD
Lurasidone—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0432	0.117	CbGbCtD
Lurasidone—CYP3A4—Cholecalciferol—osteoporosis	0.0346	0.0934	CbGbCtD
Lurasidone—CYP3A4—Conjugated Estrogens—osteoporosis	0.0317	0.0858	CbGbCtD
Lurasidone—CYP3A4—Estradiol—osteoporosis	0.0279	0.0753	CbGbCtD
Lurasidone—Pruritus—Etidronic acid—osteoporosis	0.000615	0.00114	CcSEcCtD
Lurasidone—Gastrointestinal pain—Estropipate—osteoporosis	0.000615	0.00114	CcSEcCtD
Lurasidone—Decreased appetite—Calcitriol—osteoporosis	0.000614	0.00114	CcSEcCtD
Lurasidone—Mental disorder—Conjugated Estrogens—osteoporosis	0.000613	0.00114	CcSEcCtD
Lurasidone—Back pain—Zoledronate—osteoporosis	0.000612	0.00114	CcSEcCtD
Lurasidone—Malnutrition—Conjugated Estrogens—osteoporosis	0.000609	0.00113	CcSEcCtD
Lurasidone—Loss of consciousness—Pamidronate—osteoporosis	0.000608	0.00113	CcSEcCtD
Lurasidone—Muscle spasms—Zoledronate—osteoporosis	0.000608	0.00113	CcSEcCtD
Lurasidone—Dry mouth—Risedronate—osteoporosis	0.000606	0.00113	CcSEcCtD
Lurasidone—Urinary tract infection—Estradiol—osteoporosis	0.000606	0.00113	CcSEcCtD
Lurasidone—Gastrointestinal pain—Alendronate—osteoporosis	0.000606	0.00113	CcSEcCtD
Lurasidone—Infection—Ethinyl Estradiol—osteoporosis	0.000605	0.00113	CcSEcCtD
Lurasidone—Flatulence—Conjugated Estrogens—osteoporosis	0.0006	0.00112	CcSEcCtD
Lurasidone—Convulsion—Pamidronate—osteoporosis	0.0006	0.00112	CcSEcCtD
Lurasidone—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.000598	0.00111	CcSEcCtD
Lurasidone—Hypertension—Pamidronate—osteoporosis	0.000598	0.00111	CcSEcCtD
Lurasidone—Vision blurred—Zoledronate—osteoporosis	0.000596	0.00111	CcSEcCtD
Lurasidone—Gastrointestinal pain—Raloxifene—osteoporosis	0.000596	0.00111	CcSEcCtD
Lurasidone—Diarrhoea—Etidronic acid—osteoporosis	0.000595	0.00111	CcSEcCtD
Lurasidone—Abdominal pain—Estropipate—osteoporosis	0.000594	0.00111	CcSEcCtD
Lurasidone—Tremor—Zoledronate—osteoporosis	0.000592	0.0011	CcSEcCtD
Lurasidone—Skin disorder—Ethinyl Estradiol—osteoporosis	0.000592	0.0011	CcSEcCtD
Lurasidone—Infection—Risedronate—osteoporosis	0.00059	0.0011	CcSEcCtD
Lurasidone—Hepatobiliary disease—Estradiol—osteoporosis	0.00059	0.0011	CcSEcCtD
Lurasidone—Gastrointestinal pain—Ibandronate—osteoporosis	0.00059	0.0011	CcSEcCtD
Lurasidone—Myalgia—Pamidronate—osteoporosis	0.000589	0.0011	CcSEcCtD
Lurasidone—Back pain—Conjugated Estrogens—osteoporosis	0.000589	0.0011	CcSEcCtD
Lurasidone—Anxiety—Pamidronate—osteoporosis	0.000587	0.00109	CcSEcCtD
Lurasidone—Abdominal pain—Alendronate—osteoporosis	0.000585	0.00109	CcSEcCtD
Lurasidone—Muscle spasms—Conjugated Estrogens—osteoporosis	0.000585	0.00109	CcSEcCtD
Lurasidone—Shock—Risedronate—osteoporosis	0.000585	0.00109	CcSEcCtD
Lurasidone—Anaemia—Zoledronate—osteoporosis	0.000584	0.00109	CcSEcCtD
Lurasidone—Nervous system disorder—Risedronate—osteoporosis	0.000583	0.00108	CcSEcCtD
Lurasidone—Agitation—Zoledronate—osteoporosis	0.000581	0.00108	CcSEcCtD
Lurasidone—Angioedema—Zoledronate—osteoporosis	0.000578	0.00107	CcSEcCtD
Lurasidone—Skin disorder—Risedronate—osteoporosis	0.000577	0.00107	CcSEcCtD
Lurasidone—Gastrointestinal pain—Calcitriol—osteoporosis	0.000577	0.00107	CcSEcCtD
Lurasidone—Abdominal pain—Raloxifene—osteoporosis	0.000576	0.00107	CcSEcCtD
Lurasidone—Vision blurred—Conjugated Estrogens—osteoporosis	0.000574	0.00107	CcSEcCtD
Lurasidone—Malaise—Zoledronate—osteoporosis	0.00057	0.00106	CcSEcCtD
Lurasidone—Abdominal pain—Ibandronate—osteoporosis	0.00057	0.00106	CcSEcCtD
Lurasidone—Vertigo—Zoledronate—osteoporosis	0.000568	0.00106	CcSEcCtD
Lurasidone—Syncope—Zoledronate—osteoporosis	0.000567	0.00106	CcSEcCtD
Lurasidone—Leukopenia—Zoledronate—osteoporosis	0.000566	0.00105	CcSEcCtD
Lurasidone—Infection—Pamidronate—osteoporosis	0.000561	0.00104	CcSEcCtD
Lurasidone—Abdominal pain—Calcitriol—osteoporosis	0.000558	0.00104	CcSEcCtD
Lurasidone—Angioedema—Conjugated Estrogens—osteoporosis	0.000556	0.00104	CcSEcCtD
Lurasidone—Shock—Pamidronate—osteoporosis	0.000556	0.00103	CcSEcCtD
Lurasidone—Loss of consciousness—Zoledronate—osteoporosis	0.000556	0.00103	CcSEcCtD
Lurasidone—Nervous system disorder—Pamidronate—osteoporosis	0.000554	0.00103	CcSEcCtD
Lurasidone—Urinary tract disorder—Estradiol—osteoporosis	0.000553	0.00103	CcSEcCtD
Lurasidone—Vomiting—Etidronic acid—osteoporosis	0.000553	0.00103	CcSEcCtD
Lurasidone—Tachycardia—Pamidronate—osteoporosis	0.000551	0.00103	CcSEcCtD
Lurasidone—Connective tissue disorder—Estradiol—osteoporosis	0.00055	0.00102	CcSEcCtD
Lurasidone—Urethral disorder—Estradiol—osteoporosis	0.000549	0.00102	CcSEcCtD
Lurasidone—Rash—Etidronic acid—osteoporosis	0.000548	0.00102	CcSEcCtD
Lurasidone—Convulsion—Zoledronate—osteoporosis	0.000548	0.00102	CcSEcCtD
Lurasidone—Dermatitis—Etidronic acid—osteoporosis	0.000547	0.00102	CcSEcCtD
Lurasidone—Vertigo—Conjugated Estrogens—osteoporosis	0.000547	0.00102	CcSEcCtD
Lurasidone—Hyperhidrosis—Pamidronate—osteoporosis	0.000546	0.00102	CcSEcCtD
Lurasidone—Syncope—Conjugated Estrogens—osteoporosis	0.000546	0.00102	CcSEcCtD
Lurasidone—Hypertension—Zoledronate—osteoporosis	0.000546	0.00102	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000541	0.00101	CcSEcCtD
Lurasidone—Asthenia—Estropipate—osteoporosis	0.000539	0.001	CcSEcCtD
Lurasidone—Myalgia—Zoledronate—osteoporosis	0.000538	0.001	CcSEcCtD
Lurasidone—Insomnia—Risedronate—osteoporosis	0.000537	0.001	CcSEcCtD
Lurasidone—Anxiety—Zoledronate—osteoporosis	0.000536	0.000998	CcSEcCtD
Lurasidone—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000535	0.000996	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000535	0.000995	CcSEcCtD
Lurasidone—Pruritus—Estropipate—osteoporosis	0.000532	0.00099	CcSEcCtD
Lurasidone—Asthenia—Alendronate—osteoporosis	0.000531	0.000989	CcSEcCtD
Lurasidone—Dyspnoea—Risedronate—osteoporosis	0.00053	0.000986	CcSEcCtD
Lurasidone—Hypotension—Pamidronate—osteoporosis	0.000528	0.000982	CcSEcCtD
Lurasidone—Convulsion—Conjugated Estrogens—osteoporosis	0.000527	0.000981	CcSEcCtD
Lurasidone—Dry mouth—Zoledronate—osteoporosis	0.000526	0.00098	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000526	0.000979	CcSEcCtD
Lurasidone—Fatigue—Ethinyl Estradiol—osteoporosis	0.000525	0.000978	CcSEcCtD
Lurasidone—Pruritus—Alendronate—osteoporosis	0.000524	0.000975	CcSEcCtD
Lurasidone—Dyspepsia—Risedronate—osteoporosis	0.000523	0.000973	CcSEcCtD
Lurasidone—Eye disorder—Estradiol—osteoporosis	0.000523	0.000973	CcSEcCtD
Lurasidone—Cardiac disorder—Estradiol—osteoporosis	0.000519	0.000967	CcSEcCtD
Lurasidone—Myalgia—Conjugated Estrogens—osteoporosis	0.000518	0.000964	CcSEcCtD
Lurasidone—Asthenia—Ibandronate—osteoporosis	0.000517	0.000963	CcSEcCtD
Lurasidone—Anxiety—Conjugated Estrogens—osteoporosis	0.000516	0.000961	CcSEcCtD
Lurasidone—Nausea—Etidronic acid—osteoporosis	0.000516	0.000961	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000515	0.000958	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000515	0.000958	CcSEcCtD
Lurasidone—Diarrhoea—Estropipate—osteoporosis	0.000514	0.000957	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Risedronate—osteoporosis	0.000513	0.000955	CcSEcCtD
Lurasidone—Infection—Zoledronate—osteoporosis	0.000513	0.000954	CcSEcCtD
Lurasidone—Fatigue—Risedronate—osteoporosis	0.000512	0.000953	CcSEcCtD
Lurasidone—Insomnia—Pamidronate—osteoporosis	0.000511	0.000951	CcSEcCtD
Lurasidone—Pruritus—Ibandronate—osteoporosis	0.00051	0.000949	CcSEcCtD
Lurasidone—Angiopathy—Estradiol—osteoporosis	0.000508	0.000945	CcSEcCtD
Lurasidone—Shock—Zoledronate—osteoporosis	0.000508	0.000945	CcSEcCtD
Lurasidone—Diarrhoea—Alendronate—osteoporosis	0.000507	0.000943	CcSEcCtD
Lurasidone—Asthenia—Calcitriol—osteoporosis	0.000506	0.000942	CcSEcCtD
Lurasidone—Nervous system disorder—Zoledronate—osteoporosis	0.000506	0.000942	CcSEcCtD
Lurasidone—Dyspnoea—Pamidronate—osteoporosis	0.000504	0.000937	CcSEcCtD
Lurasidone—Tachycardia—Zoledronate—osteoporosis	0.000504	0.000937	CcSEcCtD
Lurasidone—Somnolence—Pamidronate—osteoporosis	0.000502	0.000934	CcSEcCtD
Lurasidone—Skin disorder—Zoledronate—osteoporosis	0.000501	0.000933	CcSEcCtD
Lurasidone—Pruritus—Calcitriol—osteoporosis	0.000499	0.000929	CcSEcCtD
Lurasidone—Hyperhidrosis—Zoledronate—osteoporosis	0.000499	0.000928	CcSEcCtD
Lurasidone—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000498	0.000927	CcSEcCtD
Lurasidone—Diarrhoea—Raloxifene—osteoporosis	0.000498	0.000927	CcSEcCtD
Lurasidone—Dyspepsia—Pamidronate—osteoporosis	0.000497	0.000925	CcSEcCtD
Lurasidone—Dizziness—Estropipate—osteoporosis	0.000497	0.000925	CcSEcCtD
Lurasidone—Infection—Conjugated Estrogens—osteoporosis	0.000494	0.000918	CcSEcCtD
Lurasidone—Diarrhoea—Ibandronate—osteoporosis	0.000493	0.000918	CcSEcCtD
Lurasidone—Decreased appetite—Pamidronate—osteoporosis	0.000491	0.000914	CcSEcCtD
Lurasidone—Mental disorder—Estradiol—osteoporosis	0.00049	0.000912	CcSEcCtD
Lurasidone—Dizziness—Alendronate—osteoporosis	0.00049	0.000911	CcSEcCtD
Lurasidone—Shock—Conjugated Estrogens—osteoporosis	0.000489	0.00091	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000488	0.000908	CcSEcCtD
Lurasidone—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000487	0.000907	CcSEcCtD
Lurasidone—Malnutrition—Estradiol—osteoporosis	0.000487	0.000907	CcSEcCtD
Lurasidone—Fatigue—Pamidronate—osteoporosis	0.000487	0.000906	CcSEcCtD
Lurasidone—Gastrointestinal pain—Risedronate—osteoporosis	0.000486	0.000904	CcSEcCtD
Lurasidone—Tachycardia—Conjugated Estrogens—osteoporosis	0.000485	0.000902	CcSEcCtD
Lurasidone—Diarrhoea—Calcitriol—osteoporosis	0.000483	0.000899	CcSEcCtD
Lurasidone—Skin disorder—Conjugated Estrogens—osteoporosis	0.000483	0.000898	CcSEcCtD
Lurasidone—Hypotension—Zoledronate—osteoporosis	0.000482	0.000897	CcSEcCtD
Lurasidone—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000482	0.000897	CcSEcCtD
Lurasidone—Dizziness—Raloxifene—osteoporosis	0.000482	0.000896	CcSEcCtD
Lurasidone—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.00048	0.000894	CcSEcCtD
Lurasidone—Flatulence—Estradiol—osteoporosis	0.00048	0.000893	CcSEcCtD
Lurasidone—Vomiting—Estropipate—osteoporosis	0.000478	0.00089	CcSEcCtD
Lurasidone—Dizziness—Ibandronate—osteoporosis	0.000477	0.000887	CcSEcCtD
Lurasidone—Rash—Estropipate—osteoporosis	0.000474	0.000882	CcSEcCtD
Lurasidone—Dermatitis—Estropipate—osteoporosis	0.000474	0.000881	CcSEcCtD
Lurasidone—Back pain—Estradiol—osteoporosis	0.000471	0.000877	CcSEcCtD
Lurasidone—Vomiting—Alendronate—osteoporosis	0.000471	0.000876	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.00047	0.000875	CcSEcCtD
Lurasidone—Abdominal pain—Risedronate—osteoporosis	0.00047	0.000874	CcSEcCtD
Lurasidone—Muscle spasms—Estradiol—osteoporosis	0.000468	0.000872	CcSEcCtD
Lurasidone—Rash—Alendronate—osteoporosis	0.000467	0.000869	CcSEcCtD
Lurasidone—Insomnia—Zoledronate—osteoporosis	0.000467	0.000868	CcSEcCtD
Lurasidone—Dermatitis—Alendronate—osteoporosis	0.000466	0.000868	CcSEcCtD
Lurasidone—Hypotension—Conjugated Estrogens—osteoporosis	0.000464	0.000864	CcSEcCtD
Lurasidone—Vomiting—Raloxifene—osteoporosis	0.000463	0.000862	CcSEcCtD
Lurasidone—Gastrointestinal pain—Pamidronate—osteoporosis	0.000462	0.00086	CcSEcCtD
Lurasidone—Dyspnoea—Zoledronate—osteoporosis	0.00046	0.000856	CcSEcCtD
Lurasidone—Rash—Raloxifene—osteoporosis	0.000459	0.000855	CcSEcCtD
Lurasidone—Dermatitis—Raloxifene—osteoporosis	0.000459	0.000854	CcSEcCtD
Lurasidone—Somnolence—Zoledronate—osteoporosis	0.000459	0.000854	CcSEcCtD
Lurasidone—Vomiting—Ibandronate—osteoporosis	0.000458	0.000853	CcSEcCtD
Lurasidone—Tremor—Estradiol—osteoporosis	0.000456	0.000849	CcSEcCtD
Lurasidone—Rash—Ibandronate—osteoporosis	0.000455	0.000846	CcSEcCtD
Lurasidone—Dermatitis—Ibandronate—osteoporosis	0.000454	0.000845	CcSEcCtD
Lurasidone—Dyspepsia—Zoledronate—osteoporosis	0.000454	0.000845	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000453	0.000842	CcSEcCtD
Lurasidone—Insomnia—Conjugated Estrogens—osteoporosis	0.000449	0.000836	CcSEcCtD
Lurasidone—Vomiting—Calcitriol—osteoporosis	0.000449	0.000835	CcSEcCtD
Lurasidone—Decreased appetite—Zoledronate—osteoporosis	0.000449	0.000835	CcSEcCtD
Lurasidone—Agitation—Estradiol—osteoporosis	0.000448	0.000833	CcSEcCtD
Lurasidone—Nausea—Estropipate—osteoporosis	0.000447	0.000831	CcSEcCtD
Lurasidone—Abdominal pain—Pamidronate—osteoporosis	0.000447	0.000831	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000445	0.000829	CcSEcCtD
Lurasidone—Angioedema—Estradiol—osteoporosis	0.000445	0.000828	CcSEcCtD
Lurasidone—Rash—Calcitriol—osteoporosis	0.000445	0.000828	CcSEcCtD
Lurasidone—Fatigue—Zoledronate—osteoporosis	0.000445	0.000828	CcSEcCtD
Lurasidone—Dermatitis—Calcitriol—osteoporosis	0.000445	0.000827	CcSEcCtD
Lurasidone—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000443	0.000824	CcSEcCtD
Lurasidone—Somnolence—Conjugated Estrogens—osteoporosis	0.000442	0.000822	CcSEcCtD
Lurasidone—Nausea—Alendronate—osteoporosis	0.00044	0.000819	CcSEcCtD
Lurasidone—Malaise—Estradiol—osteoporosis	0.000439	0.000818	CcSEcCtD
Lurasidone—Vertigo—Estradiol—osteoporosis	0.000438	0.000815	CcSEcCtD
Lurasidone—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000437	0.000814	CcSEcCtD
Lurasidone—Asthenia—Ethinyl Estradiol—osteoporosis	0.000437	0.000814	CcSEcCtD
Lurasidone—Syncope—Estradiol—osteoporosis	0.000437	0.000813	CcSEcCtD
Lurasidone—Nausea—Raloxifene—osteoporosis	0.000433	0.000805	CcSEcCtD
Lurasidone—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000432	0.000804	CcSEcCtD
Lurasidone—Pruritus—Ethinyl Estradiol—osteoporosis	0.000431	0.000802	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000429	0.000798	CcSEcCtD
Lurasidone—Fatigue—Conjugated Estrogens—osteoporosis	0.000428	0.000797	CcSEcCtD
Lurasidone—Nausea—Ibandronate—osteoporosis	0.000428	0.000797	CcSEcCtD
Lurasidone—Loss of consciousness—Estradiol—osteoporosis	0.000428	0.000797	CcSEcCtD
Lurasidone—Asthenia—Risedronate—osteoporosis	0.000426	0.000793	CcSEcCtD
Lurasidone—Gastrointestinal pain—Zoledronate—osteoporosis	0.000422	0.000785	CcSEcCtD
Lurasidone—Hypertension—Estradiol—osteoporosis	0.000421	0.000783	CcSEcCtD
Lurasidone—Pruritus—Risedronate—osteoporosis	0.00042	0.000782	CcSEcCtD
Lurasidone—Nausea—Calcitriol—osteoporosis	0.000419	0.00078	CcSEcCtD
Lurasidone—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000417	0.000776	CcSEcCtD
Lurasidone—Myalgia—Estradiol—osteoporosis	0.000415	0.000772	CcSEcCtD
Lurasidone—Anxiety—Estradiol—osteoporosis	0.000413	0.000769	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000412	0.000767	CcSEcCtD
Lurasidone—Abdominal pain—Zoledronate—osteoporosis	0.000408	0.000759	CcSEcCtD
Lurasidone—Diarrhoea—Risedronate—osteoporosis	0.000407	0.000757	CcSEcCtD
Lurasidone—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000406	0.000756	CcSEcCtD
Lurasidone—Dry mouth—Estradiol—osteoporosis	0.000406	0.000755	CcSEcCtD
Lurasidone—Asthenia—Pamidronate—osteoporosis	0.000405	0.000754	CcSEcCtD
Lurasidone—Dizziness—Ethinyl Estradiol—osteoporosis	0.000403	0.00075	CcSEcCtD
Lurasidone—Pruritus—Pamidronate—osteoporosis	0.0004	0.000744	CcSEcCtD
Lurasidone—Infection—Estradiol—osteoporosis	0.000395	0.000735	CcSEcCtD
Lurasidone—Dizziness—Risedronate—osteoporosis	0.000393	0.000731	CcSEcCtD
Lurasidone—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000393	0.000731	CcSEcCtD
Lurasidone—Shock—Estradiol—osteoporosis	0.000391	0.000728	CcSEcCtD
Lurasidone—Nervous system disorder—Estradiol—osteoporosis	0.00039	0.000726	CcSEcCtD
Lurasidone—Tachycardia—Estradiol—osteoporosis	0.000388	0.000722	CcSEcCtD
Lurasidone—Vomiting—Ethinyl Estradiol—osteoporosis	0.000387	0.000721	CcSEcCtD
Lurasidone—Diarrhoea—Pamidronate—osteoporosis	0.000386	0.000719	CcSEcCtD
Lurasidone—Skin disorder—Estradiol—osteoporosis	0.000386	0.000719	CcSEcCtD
Lurasidone—Hyperhidrosis—Estradiol—osteoporosis	0.000384	0.000715	CcSEcCtD
Lurasidone—Rash—Ethinyl Estradiol—osteoporosis	0.000384	0.000715	CcSEcCtD
Lurasidone—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000384	0.000714	CcSEcCtD
Lurasidone—Vomiting—Risedronate—osteoporosis	0.000378	0.000703	CcSEcCtD
Lurasidone—Rash—Risedronate—osteoporosis	0.000375	0.000697	CcSEcCtD
Lurasidone—Dermatitis—Risedronate—osteoporosis	0.000374	0.000697	CcSEcCtD
Lurasidone—Dizziness—Pamidronate—osteoporosis	0.000374	0.000695	CcSEcCtD
Lurasidone—Asthenia—Zoledronate—osteoporosis	0.00037	0.000689	CcSEcCtD
Lurasidone—Pruritus—Zoledronate—osteoporosis	0.000365	0.000679	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000362	0.000674	CcSEcCtD
Lurasidone—Nausea—Ethinyl Estradiol—osteoporosis	0.000362	0.000674	CcSEcCtD
Lurasidone—Insomnia—Estradiol—osteoporosis	0.00036	0.000669	CcSEcCtD
Lurasidone—Vomiting—Pamidronate—osteoporosis	0.000359	0.000668	CcSEcCtD
Lurasidone—Asthenia—Conjugated Estrogens—osteoporosis	0.000356	0.000663	CcSEcCtD
Lurasidone—Rash—Pamidronate—osteoporosis	0.000356	0.000663	CcSEcCtD
Lurasidone—Dermatitis—Pamidronate—osteoporosis	0.000356	0.000662	CcSEcCtD
Lurasidone—Dyspnoea—Estradiol—osteoporosis	0.000354	0.00066	CcSEcCtD
Lurasidone—Somnolence—Estradiol—osteoporosis	0.000353	0.000658	CcSEcCtD
Lurasidone—Diarrhoea—Zoledronate—osteoporosis	0.000353	0.000657	CcSEcCtD
Lurasidone—Nausea—Risedronate—osteoporosis	0.000353	0.000657	CcSEcCtD
Lurasidone—Pruritus—Conjugated Estrogens—osteoporosis	0.000351	0.000654	CcSEcCtD
Lurasidone—Dyspepsia—Estradiol—osteoporosis	0.00035	0.000651	CcSEcCtD
Lurasidone—Decreased appetite—Estradiol—osteoporosis	0.000346	0.000643	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Estradiol—osteoporosis	0.000343	0.000639	CcSEcCtD
Lurasidone—Fatigue—Estradiol—osteoporosis	0.000343	0.000638	CcSEcCtD
Lurasidone—Dizziness—Zoledronate—osteoporosis	0.000341	0.000635	CcSEcCtD
Lurasidone—Diarrhoea—Conjugated Estrogens—osteoporosis	0.00034	0.000633	CcSEcCtD
Lurasidone—Nausea—Pamidronate—osteoporosis	0.000336	0.000624	CcSEcCtD
Lurasidone—Dizziness—Conjugated Estrogens—osteoporosis	0.000329	0.000611	CcSEcCtD
Lurasidone—Vomiting—Zoledronate—osteoporosis	0.000328	0.00061	CcSEcCtD
Lurasidone—Rash—Zoledronate—osteoporosis	0.000325	0.000605	CcSEcCtD
Lurasidone—Gastrointestinal pain—Estradiol—osteoporosis	0.000325	0.000605	CcSEcCtD
Lurasidone—Dermatitis—Zoledronate—osteoporosis	0.000325	0.000605	CcSEcCtD
Lurasidone—Vomiting—Conjugated Estrogens—osteoporosis	0.000316	0.000588	CcSEcCtD
Lurasidone—Abdominal pain—Estradiol—osteoporosis	0.000314	0.000585	CcSEcCtD
Lurasidone—Rash—Conjugated Estrogens—osteoporosis	0.000313	0.000583	CcSEcCtD
Lurasidone—Dermatitis—Conjugated Estrogens—osteoporosis	0.000313	0.000582	CcSEcCtD
Lurasidone—Nausea—Zoledronate—osteoporosis	0.000306	0.00057	CcSEcCtD
Lurasidone—Nausea—Conjugated Estrogens—osteoporosis	0.000295	0.000549	CcSEcCtD
Lurasidone—Asthenia—Estradiol—osteoporosis	0.000285	0.000531	CcSEcCtD
Lurasidone—Pruritus—Estradiol—osteoporosis	0.000281	0.000524	CcSEcCtD
Lurasidone—Diarrhoea—Estradiol—osteoporosis	0.000272	0.000506	CcSEcCtD
Lurasidone—Dizziness—Estradiol—osteoporosis	0.000263	0.000489	CcSEcCtD
Lurasidone—Vomiting—Estradiol—osteoporosis	0.000253	0.00047	CcSEcCtD
Lurasidone—Rash—Estradiol—osteoporosis	0.000251	0.000467	CcSEcCtD
Lurasidone—Dermatitis—Estradiol—osteoporosis	0.00025	0.000466	CcSEcCtD
Lurasidone—Nausea—Estradiol—osteoporosis	0.000236	0.00044	CcSEcCtD
Lurasidone—DRD2—GPCR ligand binding—POMC—osteoporosis	6.5e-05	0.000702	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—PTHLH—osteoporosis	6.48e-05	0.000701	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—FGB—osteoporosis	6.44e-05	0.000695	CbGpPWpGaD
Lurasidone—HTR2A—GPCR ligand binding—POMC—osteoporosis	6.4e-05	0.000691	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—CALCA—osteoporosis	6.38e-05	0.000689	CbGpPWpGaD
Lurasidone—HTR2A—SIDS Susceptibility Pathways—IL6—osteoporosis	6.37e-05	0.000688	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—CALCA—osteoporosis	6.29e-05	0.000679	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—CALCA—osteoporosis	6.28e-05	0.000678	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—PSMA5—osteoporosis	6.21e-05	0.000671	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—PSMA2—osteoporosis	6.21e-05	0.000671	CbGpPWpGaD
Lurasidone—ADRA2C—Hemostasis—IGF1—osteoporosis	6.16e-05	0.000666	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—TLN1—osteoporosis	6.16e-05	0.000665	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—TLN1—osteoporosis	6.06e-05	0.000654	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—P4HB—osteoporosis	6.05e-05	0.000653	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—TPI1—osteoporosis	6.04e-05	0.000653	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—PTH—osteoporosis	5.88e-05	0.000635	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—P4HB—osteoporosis	5.85e-05	0.000632	CbGpPWpGaD
Lurasidone—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	5.82e-05	0.000629	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR ligand binding—POMC—osteoporosis	5.82e-05	0.000629	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—CALCA—osteoporosis	5.79e-05	0.000626	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—RAP1A—osteoporosis	5.78e-05	0.000624	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—CNR2—osteoporosis	5.73e-05	0.000619	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—CALCA—osteoporosis	5.71e-05	0.000617	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—PTH—osteoporosis	5.69e-05	0.000615	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—ADCY5—osteoporosis	5.69e-05	0.000615	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—P4HB—osteoporosis	5.68e-05	0.000614	CbGpPWpGaD
Lurasidone—HTR7—GPCR downstream signaling—POMC—osteoporosis	5.65e-05	0.00061	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—NFATC1—osteoporosis	5.64e-05	0.000609	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—DKK1—osteoporosis	5.59e-05	0.000604	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—RAP1A—osteoporosis	5.59e-05	0.000604	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—GAPDH—osteoporosis	5.58e-05	0.000603	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—CNR2—osteoporosis	5.55e-05	0.000599	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—TLN1—osteoporosis	5.51e-05	0.000595	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—ADCY5—osteoporosis	5.51e-05	0.000595	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—NFATC1—osteoporosis	5.46e-05	0.00059	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—RAP1A—osteoporosis	5.43e-05	0.000587	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—DKK1—osteoporosis	5.41e-05	0.000585	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—ENO1—osteoporosis	5.41e-05	0.000584	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—WNT1—osteoporosis	5.39e-05	0.000582	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—PSMA5—osteoporosis	5.33e-05	0.000576	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—PSMA2—osteoporosis	5.33e-05	0.000576	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—P4HB—osteoporosis	5.31e-05	0.000574	CbGpPWpGaD
Lurasidone—DRD2—Circadian rythm related genes—IL6—osteoporosis	5.29e-05	0.000571	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—KL—osteoporosis	5.26e-05	0.000568	CbGpPWpGaD
Lurasidone—CYP3A4—Biological oxidations—POMC—osteoporosis	5.26e-05	0.000568	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—FGA—osteoporosis	5.24e-05	0.000566	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—P4HB—osteoporosis	5.22e-05	0.000564	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—WNT1—osteoporosis	5.21e-05	0.000563	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—ADCY5—osteoporosis	5.17e-05	0.000558	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—PTH—osteoporosis	5.16e-05	0.000558	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—POMC—osteoporosis	5.13e-05	0.000554	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—PTH—osteoporosis	5.08e-05	0.000549	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—RAP1A—osteoporosis	5.08e-05	0.000548	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—FGA—osteoporosis	5.07e-05	0.000548	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—CNR2—osteoporosis	5.03e-05	0.000544	CbGpPWpGaD
Lurasidone—ADRA2A—Hemostasis—IGF1—osteoporosis	5.01e-05	0.000541	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—IL6R—osteoporosis	5e-05	0.00054	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—ADCY5—osteoporosis	5e-05	0.00054	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—ADCY5—osteoporosis	5e-05	0.00054	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—RAP1A—osteoporosis	4.99e-05	0.000539	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—PKM—osteoporosis	4.96e-05	0.000536	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—FDPS—osteoporosis	4.96e-05	0.000536	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—CNR2—osteoporosis	4.95e-05	0.000535	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—NFATC1—osteoporosis	4.95e-05	0.000535	CbGpPWpGaD
Lurasidone—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	4.93e-05	0.000533	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—ADCY5—osteoporosis	4.92e-05	0.000531	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—DKK1—osteoporosis	4.91e-05	0.000531	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—PTHLH—osteoporosis	4.87e-05	0.000527	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—BMP2—osteoporosis	4.87e-05	0.000527	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—NFATC1—osteoporosis	4.87e-05	0.000526	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—DKK1—osteoporosis	4.83e-05	0.000522	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—FGB—osteoporosis	4.77e-05	0.000515	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—P4HB—osteoporosis	4.75e-05	0.000513	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—WNT1—osteoporosis	4.73e-05	0.000511	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—PTHLH—osteoporosis	4.72e-05	0.000509	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—BMP2—osteoporosis	4.72e-05	0.000509	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—GPD2—osteoporosis	4.7e-05	0.000508	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—PGLS—osteoporosis	4.7e-05	0.000508	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—WNT1—osteoporosis	4.66e-05	0.000503	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—PTH—osteoporosis	4.62e-05	0.000499	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—FGB—osteoporosis	4.62e-05	0.000499	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—PSMA2—osteoporosis	4.6e-05	0.000497	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—PSMA5—osteoporosis	4.6e-05	0.000497	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—FGA—osteoporosis	4.6e-05	0.000497	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—RAP1A—osteoporosis	4.54e-05	0.000491	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—ADCY5—osteoporosis	4.54e-05	0.00049	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—FGA—osteoporosis	4.53e-05	0.000489	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—CNR2—osteoporosis	4.51e-05	0.000487	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—ADCY5—osteoporosis	4.47e-05	0.000483	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—ADCY5—osteoporosis	4.46e-05	0.000482	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—PSMA5—osteoporosis	4.46e-05	0.000481	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—PSMA2—osteoporosis	4.46e-05	0.000481	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—NFATC1—osteoporosis	4.43e-05	0.000479	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—DKK1—osteoporosis	4.4e-05	0.000475	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—ENO1—osteoporosis	4.39e-05	0.000474	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—PSMA2—osteoporosis	4.33e-05	0.000468	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—PSMA5—osteoporosis	4.33e-05	0.000468	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—CYP19A1—osteoporosis	4.32e-05	0.000467	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—ATIC—osteoporosis	4.3e-05	0.000464	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—PNP—osteoporosis	4.3e-05	0.000464	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—CALCA—osteoporosis	4.29e-05	0.000464	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—PTHLH—osteoporosis	4.28e-05	0.000462	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—BMP2—osteoporosis	4.28e-05	0.000462	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—WNT1—osteoporosis	4.24e-05	0.000458	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—PTHLH—osteoporosis	4.21e-05	0.000455	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—BMP2—osteoporosis	4.21e-05	0.000455	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—FGB—osteoporosis	4.19e-05	0.000452	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—POMC—osteoporosis	4.18e-05	0.000452	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—CALCA—osteoporosis	4.15e-05	0.000449	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—FGA—osteoporosis	4.12e-05	0.000445	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—FGB—osteoporosis	4.12e-05	0.000445	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—ADCY5—osteoporosis	4.12e-05	0.000445	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—ADCY5—osteoporosis	4.06e-05	0.000439	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—POMC—osteoporosis	4.05e-05	0.000437	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—PSMA5—osteoporosis	4.04e-05	0.000437	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—PSMA2—osteoporosis	4.04e-05	0.000437	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—SPP1—osteoporosis	3.98e-05	0.00043	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—PSMA2—osteoporosis	3.98e-05	0.00043	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—PSMA5—osteoporosis	3.98e-05	0.00043	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—KL—osteoporosis	3.9e-05	0.000421	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—PTHLH—osteoporosis	3.83e-05	0.000414	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—BMP2—osteoporosis	3.83e-05	0.000414	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—POMC—osteoporosis	3.8e-05	0.000411	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—KL—osteoporosis	3.77e-05	0.000407	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—CALCA—osteoporosis	3.77e-05	0.000407	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—FGB—osteoporosis	3.75e-05	0.000405	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—IL6R—osteoporosis	3.71e-05	0.000401	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—CALCA—osteoporosis	3.71e-05	0.0004	CbGpPWpGaD
Lurasidone—ADRA2C—Hemostasis—TGFB1—osteoporosis	3.7e-05	0.000399	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—POMC—osteoporosis	3.68e-05	0.000397	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—POMC—osteoporosis	3.67e-05	0.000397	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—OXCT1—osteoporosis	3.66e-05	0.000395	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CA2—osteoporosis	3.66e-05	0.000395	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—PSMA2—osteoporosis	3.62e-05	0.000391	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—PSMA5—osteoporosis	3.62e-05	0.000391	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—POMC—osteoporosis	3.62e-05	0.000391	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—IRS2—osteoporosis	3.6e-05	0.000389	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—IL6R—osteoporosis	3.59e-05	0.000388	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—MGLL—osteoporosis	3.56e-05	0.000385	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—ADCY5—osteoporosis	3.53e-05	0.000382	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—LEP—osteoporosis	3.53e-05	0.000381	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—GPX1—osteoporosis	3.52e-05	0.00038	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—CYP19A1—osteoporosis	3.51e-05	0.000379	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—KL—osteoporosis	3.42e-05	0.00037	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—CALCA—osteoporosis	3.37e-05	0.000364	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—ESR1—osteoporosis	3.37e-05	0.000364	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—KL—osteoporosis	3.37e-05	0.000364	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—POMC—osteoporosis	3.34e-05	0.00036	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—POMC—osteoporosis	3.29e-05	0.000355	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—POMC—osteoporosis	3.28e-05	0.000355	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—IL6R—osteoporosis	3.25e-05	0.000352	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—MTHFR—osteoporosis	3.25e-05	0.000351	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—IL6R—osteoporosis	3.2e-05	0.000346	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—IRS1—osteoporosis	3.15e-05	0.00034	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—KL—osteoporosis	3.06e-05	0.000331	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—ADCY5—osteoporosis	3.05e-05	0.00033	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—POMC—osteoporosis	3.03e-05	0.000327	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—IDH2—osteoporosis	3.03e-05	0.000327	CbGpPWpGaD
Lurasidone—ADRA2A—Hemostasis—TGFB1—osteoporosis	3e-05	0.000324	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—POMC—osteoporosis	2.99e-05	0.000323	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—IL6R—osteoporosis	2.96e-05	0.000319	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—ADCY5—osteoporosis	2.95e-05	0.000319	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—SPP1—osteoporosis	2.95e-05	0.000319	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—IGF1—osteoporosis	2.91e-05	0.000315	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—IL6R—osteoporosis	2.91e-05	0.000315	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—ADCY5—osteoporosis	2.87e-05	0.00031	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—GPX1—osteoporosis	2.86e-05	0.000309	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—SPP1—osteoporosis	2.86e-05	0.000309	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CYP27A1—osteoporosis	2.85e-05	0.000308	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—ACP5—osteoporosis	2.77e-05	0.000299	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—ADCY5—osteoporosis	2.68e-05	0.00029	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—IRS2—osteoporosis	2.67e-05	0.000288	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—MTHFR—osteoporosis	2.64e-05	0.000285	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—ADCY5—osteoporosis	2.64e-05	0.000285	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—LEP—osteoporosis	2.61e-05	0.000282	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—POMC—osteoporosis	2.6e-05	0.000281	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—SPP1—osteoporosis	2.59e-05	0.00028	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—IRS2—osteoporosis	2.58e-05	0.000279	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—TPI1—osteoporosis	2.58e-05	0.000278	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—SPP1—osteoporosis	2.55e-05	0.000276	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—LEP—osteoporosis	2.53e-05	0.000273	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—ESR1—osteoporosis	2.5e-05	0.00027	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—P4HB—osteoporosis	2.42e-05	0.000262	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—ESR1—osteoporosis	2.41e-05	0.000261	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—ADCY5—osteoporosis	2.4e-05	0.000259	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—GAPDH—osteoporosis	2.38e-05	0.000257	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—IRS2—osteoporosis	2.34e-05	0.000253	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—IRS1—osteoporosis	2.33e-05	0.000252	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—SPP1—osteoporosis	2.32e-05	0.000251	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—RAP1A—osteoporosis	2.31e-05	0.00025	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—IRS2—osteoporosis	2.31e-05	0.000249	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—LEP—osteoporosis	2.29e-05	0.000248	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—LEP—osteoporosis	2.26e-05	0.000244	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—IRS1—osteoporosis	2.26e-05	0.000244	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—POMC—osteoporosis	2.25e-05	0.000243	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—IL6—osteoporosis	2.23e-05	0.000241	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—ESR1—osteoporosis	2.19e-05	0.000237	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—IL6R—osteoporosis	2.19e-05	0.000237	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—POMC—osteoporosis	2.17e-05	0.000235	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—IGF1—osteoporosis	2.16e-05	0.000233	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—ESR1—osteoporosis	2.16e-05	0.000233	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—IL6R—osteoporosis	2.12e-05	0.000229	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—POMC—osteoporosis	2.11e-05	0.000228	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—IRS2—osteoporosis	2.1e-05	0.000227	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—IGF1—osteoporosis	2.09e-05	0.000226	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—LEP—osteoporosis	2.05e-05	0.000222	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—IRS1—osteoporosis	2.05e-05	0.000221	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—IRS1—osteoporosis	2.01e-05	0.000218	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—POMC—osteoporosis	1.97e-05	0.000213	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—ESR1—osteoporosis	1.96e-05	0.000212	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—POMC—osteoporosis	1.94e-05	0.00021	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—IL6R—osteoporosis	1.92e-05	0.000208	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—IGF1—osteoporosis	1.9e-05	0.000205	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—IL6R—osteoporosis	1.89e-05	0.000204	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—ENO1—osteoporosis	1.87e-05	0.000202	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—IGF1—osteoporosis	1.87e-05	0.000202	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—PSMA2—osteoporosis	1.84e-05	0.000199	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—PSMA5—osteoporosis	1.84e-05	0.000199	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—IRS1—osteoporosis	1.83e-05	0.000198	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—POMC—osteoporosis	1.76e-05	0.000191	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—MYC—osteoporosis	1.75e-05	0.000189	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—TGFB1—osteoporosis	1.75e-05	0.000189	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—IL6R—osteoporosis	1.72e-05	0.000186	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—IGF1—osteoporosis	1.7e-05	0.000183	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—IL6—osteoporosis	1.65e-05	0.000178	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—IL6—osteoporosis	1.6e-05	0.000173	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CYP19A1—osteoporosis	1.5e-05	0.000162	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—IL6—osteoporosis	1.45e-05	0.000157	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—IL6—osteoporosis	1.43e-05	0.000154	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—IL6—osteoporosis	1.32e-05	0.000142	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—IL6—osteoporosis	1.3e-05	0.00014	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—MYC—osteoporosis	1.3e-05	0.00014	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—TGFB1—osteoporosis	1.29e-05	0.00014	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—MYC—osteoporosis	1.26e-05	0.000136	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—TGFB1—osteoporosis	1.25e-05	0.000135	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—ADCY5—osteoporosis	1.22e-05	0.000132	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—GPX1—osteoporosis	1.22e-05	0.000132	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—MYC—osteoporosis	1.14e-05	0.000123	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—TGFB1—osteoporosis	1.14e-05	0.000123	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—MTHFR—osteoporosis	1.12e-05	0.000121	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—MYC—osteoporosis	1.12e-05	0.000121	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—TGFB1—osteoporosis	1.12e-05	0.000121	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—MYC—osteoporosis	1.02e-05	0.00011	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—TGFB1—osteoporosis	1.02e-05	0.00011	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—IL6—osteoporosis	9.76e-06	0.000105	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—IL6—osteoporosis	9.44e-06	0.000102	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—POMC—osteoporosis	8.99e-06	9.71e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—IL6—osteoporosis	8.57e-06	9.25e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—IL6—osteoporosis	8.43e-06	9.1e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—IL6—osteoporosis	7.67e-06	8.28e-05	CbGpPWpGaD
